Thieme E-Books & E-Journals -
Neuropediatrics 2018; 49(S 02): S1-S69
DOI: 10.1055/s-0038-1676032
Industrial Posters
Epilepsy and Movement Disorders
Georg Thieme Verlag KG Stuttgart · New York

IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Authors

  • Tilman Polster

    1   Bethel Epilepsy Centre, Paediatric Epileptology, Bielefeld, Germany
  • Lieven Lagae

    2   Section of Pediatric Neurology, Department of Development and Regeneration, University Hospitals Gasthuisberg, Leuven, Belgium
  • Joseph Sullivan

    3   UCSF School of Medicine, Los Angeles, United States
  • Ulrich Brandl

    4   Department of Neuropediatrics, University Hospital, Jena, Germany
  • Arne Herting

    5   Epilepsie-Zentrum Bethel, Krankenhaus Mara, Kinderepileptologie, Bielefeld, Germany
  • Julia Jacobs

    6   Department of Neuropediatrics, Epilepsy Center, University Medical Center Freiburg, Freiburg, Germany
  • Gerhard Kluger

    7   Schön-Klinik Vogtareuth, Hospital for Neuropediatrics and Neurological Rehabilitation, Vogtareuth, Germany
  • Thomas Mayer

    9   Kleinwachau - Saxonian Epilepsy Centre, Radeberg, Germany
  • Axel Panzer

    10   DRK- Hospitals Berlin-Westend, Berlin, Germany
  • Milka Pringsheim

    7   Schön-Klinik Vogtareuth, Hospital for Neuropediatrics and Neurological Rehabilitation, Vogtareuth, Germany
  • Ulrich Stephani

    11   Department of Neuropediatrics, University Children’s Hospital, University Hospitals Schleswig-Holstein, Kiel, Germany
  • Markus Wolff

    12   Department of Pediatric Neurology and Developmental Medicine, University Children’s Hospital, Tübingen, Germany
  • Gail Farfel

    13   Zogenix Inc., Emeryville, California, United States
  • Bradley S. Galer

    13   Zogenix Inc., Emeryville, California, United States
  • Arnold Gammaitoni

    13   Zogenix Inc., Emeryville, California, United States
  • Michael Lock

    13   Zogenix Inc., Emeryville, California, United States
  • Arun Mistry

    14   Zogenix International Ltd, Maidenhead, Berkshire, United Kingdom
  • Glenn Morrison

    13   Zogenix Inc., Emeryville, California, United States
  • Berten Ceulemans

    15   Department of Neurology-Pediatric Neurology, Antwerp University Hospital, Antwerpen, Belgium